Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
The Vanguard Group's stake in Zentalis Pharmaceuticals, Inc. fell to 4.59% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 31, 2025
The Vanguard Group's stake in Zentalis Pharmaceuticals, Inc. fell to 4.59%, 3,271,240 shares, as a passive investor on Dec 31, 2024. Filed Jan 31, 2025 (Schedule 13G/A).
- Stake
- 4.59%
- Shares
- 3,271,240
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.59% | 3,271,240 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- The Vanguard Group
- Zentalis Pharmaceuticals, Inc. shareholders
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026